(Q38166808)

30 August 2017

Progressive supranuclear palsy: clinical and pathological diagnosis (English)

1 reference

progressive supranuclear palsy

30 August 2017

1 reference

E Tolosa

1

1 reference

PubMed ID

24283678

30 August 2017

F Valldeoriola

series ordinal

2

1 reference

PubMed ID

24283678

30 August 2017

F Cruz-Sánchez

series ordinal

3

1 reference

30 August 2017

1 September 1995

1 reference

European Journal of Neurology

30 August 2017

1 reference

30 August 2017

2

1 reference

30 August 2017

4

1 reference

30 August 2017

259-273

1 reference

Three categories of the degenerative appearance of the human cerebellar dentate nucleus. A morphometric and morphological study.

30 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.1995.TB00129.X

Presenile dementia with progressive supranuclear palsy tangles and Pick bodies: an unusual degenerative disorder involving the cerebral cortex, cerebral nuclei, and brain stem nuclei

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.1995.TB00129.X

Neurofibrillary tangles in Alzheimer's disease and progressive supranuclear palsy: antigenic similarities and differences. Microtubule-associated protein tau antigenicity is prominent in all types of tangles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.1995.TB00129.X

Progressive supranuclear palsy. Clinico-pathological study of four cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.1995.TB00129.X

Positron emission tomography study in progressive supranuclear palsy. Brain hypometabolic pattern and clinicometabolic correlations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.1995.TB00129.X

Argyrophilic grains: characteristic pathology of cerebral cortex in cases of adult onset dementia without Alzheimer changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.1995.TB00129.X

Allocortical neurofibrillary changes in progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.1995.TB00129.X

Differing patterns of striatal 18F-dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.1995.TB00129.X

Striatal D2 receptor status in patients with Parkinson's disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11C-raclopride and positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.1995.TB00129.X

Progressive supranuclear palsy: neuropathologically based diagnostic clinical criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.1995.TB00129.X

Clinical and pathological study of two patients with progressive supranuclear palsy and Alzheimer's changes. Antigenic determinants that distinguish cortical and subcortical neurofibrillary tangles

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.1995.TB00129.X

Immunohistological study of grumose degeneration of the dentate nucleus in progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.1995.TB00129.X

The clinical and pathological spectrum of Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy): a reappraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.1995.TB00129.X

Further observations in progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.1995.TB00129.X

Atypical presentation of progressive supranuclear palsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.1995.TB00129.X

Subcortical neurofibrillary degeneration presenting as Steele-Richardson-Olszewski and other related syndromes: a review of 90 pathologically verified cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.1995.TB00129.X

Abnormal Tau proteins in progressive supranuclear palsy. Similarities and differences with the neurofibrillary degeneration of the Alzheimer type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.1995.TB00129.X

Progressive subcortical gliosis and progressive supranuclear palsy can have similar clinical and PET abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.1995.TB00129.X

Progressive supranuclear palsy: neuropathologic and clinical heterogeneity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.1995.TB00129.X

Pathological overlap in cases of parkinsonism associated with neurofibrillary tangles. A study of recent cases of postencephalitic parkinsonism and comparison with progressive supranuclear palsy and Guamanian parkinsonism-dementia complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.1995.TB00129.X

Prevalence and natural history of progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.1995.TB00129.X

Constant neurofibrillary changes in the neocortex in progressive supranuclear palsy. Basic differences with Alzheimer's disease and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.1995.TB00129.X

Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.1995.TB00129.X

Parkinsonism-dementia complex, an endemic disease on the island of Guam. II. Pathological features

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.1995.TB00129.X

Neuronal loss in the pedunculopontine tegmental nucleus in Parkinson disease and in progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.1995.TB00129.X

Distribution of cortical neurofibrillary tangles in progressive supranuclear palsy: a quantitative analysis of six cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.1995.TB00129.X

Differential distribution of neurofibrillary tangles in the cerebral cortex of dementia pugilistica and Alzheimer's disease cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.1995.TB00129.X

Distribution and ultrastructure of Alzheimer's neurofibrillary tangles in postencephalitic Parkinsonism of Economo type

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.1995.TB00129.X

Frequency of Alzheimer's neurofibrillary tangles in the cerebral cortex in progressive supranuclear palsy (subcortical argyrophilic dystrophy).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.1995.TB00129.X

Motor nuclear involvement in progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.1995.TB00129.X

Contribution to clinical pathology of progressive supranuclear palsy (subcortical argyrophilic dystrophy). On the distribution of neurofirbrillary tangles in the basal ganglia and brain-stem and its clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.1995.TB00129.X

Morphological overlap between corticobasal degeneration and Pick's disease: a clinicopathological report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.1995.TB00129.X

Immunohistochemical study of a case with progressive supranuclear palsy without ophthalmoplegia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.1995.TB00129.X

Multiple system degeneration and involving thalamus, reticular formation, pallido-nigral, pallido-luysian and dentato-rubral systems. A case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.1995.TB00129.X

Epitopes that span the tau molecule are shared with paired helical filaments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.1995.TB00129.X

The clinical features and natural history of the Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.1995.TB00129.X

Catecholaminergic systems in the medulla oblongata in parkinsonian syndromes: a quantitative immunohistochemical study in Parkinson's disease, progressive supranuclear palsy, and striatonigral degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.1995.TB00129.X

Progressive supranuclear palsy: loss of choline-acetyltransferase-like immunoreactive neurons in the pontine reticular formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.1995.TB00129.X

Role of pontine nuclei damage in smooth pursuit impairment of progressive supranuclear palsy: a clinical-pathologic study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.1995.TB00129.X

Ubiquitin is associated with abnormal cytoplasmic filaments characteristic of neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.1995.TB00129.X

The topographic distribution of brain atrophy in Huntington's disease and progressive supranuclear palsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.1995.TB00129.X

Late onset dementia with argyrophilic grains and subcortical tangles or atypical progressive supranuclear palsy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.1995.TB00129.X

Pure akinesia: an atypical manifestation of progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.1995.TB00129.X

Substructure of 20 nm filaments of progressive supranuclear palsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.1995.TB00129.X

Progressive supranuclear palsy with Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.1995.TB00129.X

Glial fibrillary tangles with straight tubules in the brains of patients with progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.1995.TB00129.X

Paired helical filaments from Alzheimer disease patients contain cytoskeletal components

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.1995.TB00129.X

Filamentous aggregates in Pick's disease, progressive supranuclear palsy, and Alzheimer's disease share antigenic determinants with microtubule-associated protein, tau.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.1995.TB00129.X

Neurofibrillary tangles in progressive supranuclear palsy. Electron microscopic observations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.1995.TB00129.X

A case of progressive supranuclear palsy with widespread senile plaques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.1995.TB00129.X

PROGRESSIVE SUPRANUCLEAR PALSY. A HETEROGENEOUS DEGENERATION INVOLVING THE BRAIN STEM, BASAL GANGLIA AND CEREBELLUM WITH VERTICAL GAZE AND PSEUDOBULBAR PALSY, NUCHAL DYSTONIA AND DEMENTIA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.1995.TB00129.X

Alz 50 recognizes abnormal filaments in Alzheimer's disease and progressive supranuclear palsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.1995.TB00129.X

The basal nucleus of Meynert in patients with progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.1995.TB00129.X

Ultrastructure of Neurofibrillary Tangles in Steele-Richardson-Olszewski Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.1995.TB00129.X

Ultrastructure of neurofibrillary tangles in progressive supranuclear palsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.1995.TB00129.X

The auditory startle response in the Steele-Richardson-Olszewski syndrome and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.1995.TB00129.X

Heterogeneous system degeneration of the central nervous system associated with peripheral neuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.1995.TB00129.X

A case of progressive subcortical gliosis presenting clinically as Steele-Richardson-Olszewski syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.1995.TB00129.X

Hypertrophy of the olivary nucleus. An ultrastructural study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.1995.TB00129.X

Appearance of paired nucleated, Tau-positive glia in patients with progressive supranuclear palsy brain tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.1995.TB00129.X

Further observations on Tau-positive glia in the brains with progressive supranuclear palsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.1995.TB00129.X

Pallido-nigro-luysian atrophy, progressive supranuclear palsy and adult onset Hallervorden-Spatz disease: A case of akinesia as a predominant feature of parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.1995.TB00129.X

Immunocytochemical comparison of neurofibrillary tangles in senile dementia of Alzheimer type, progressive supranuclear palsy, and postencephalitic parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.1995.TB00129.X

10.1111/J.1468-1331.1995.TB00129.X

21 January 2018

Identifiers

DOI

1 reference

30 August 2017

1 reference

PubMed ID

24283678